Eight versus 16-week re-evaluation period in rheumatoid arthritis patients treated with leflunomide or methotrexate accompanied by moderate dose prednisone
暂无分享,去创建一个
G. Wiesmüller | C. Fiehn | E. Röther | C. Richter | S. Jacki | B. Heilig | M. Lampe | E. Rochel | I. Gao